BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months

Biotech catalysts in 2026-08

169 industry Phase 2/3 trial readout(s) and 32 FDA decision event(s). Readouts include completed (ACTUAL) and still-estimated primary completion dates in this month, any status.

← 2026-07 | 2026-09 →

FDA decision events

DateEventStatusCompanyDrugSource
2026-08-05FDA approvalapprovedTAKEDA PHARMS USA TAKORZEYFULApproved 2026-08-05: ORZEYFUL (NDA220860 ORIG1)
2026-08-05PDUFA date (company-disclosed)date passedModerna, Inc. MRNAPDUFA August 5 - Moderna, Inc.
2026-08-07Complete response lettercomplete responseITM Solucin GmbHMPACRL 2026-08-07: ITM Solucin GmbH NDA 218705 (MPA (Iutetium Lu177 edotreotide) injection)
2026-08-09FDA approvalapprovedLINDE GAS EQUIP LINNITROUS OXIDE USPApproved 2026-08-09: NITROUS OXIDE, USP (NDA221892 ORIG1)
2026-08-13FDA approvalapprovedCERVEAU LANTHEUSTAUKLARIFYApproved 2026-08-13: TAUKLARIFY (NDA220496 ORIG1)
2026-08-13FDA approvalapprovedBRISTOL MYERS SQUIBB BMYZENBEXUSApproved 2026-08-13: ZENBEXUS (NDA221075 ORIG1)
2026-08-14FDA approvalapprovedBIOCON BIOLOGICS INCYESINTEKApproved 2026-08-14: YESINTEK (BLA761406 SUPPL2)
2026-08-14FDA approvalapprovedBAXTER HLTHCARE CORP BAXSODIUM BICARBONATEApproved 2026-08-14: SODIUM BICARBONATE (NDA218524 ORIG1)
2026-08-18Complete response lettercomplete responseSamChunDang Pharm. Co., Ltd.SCD411CRL 2026-08-18: SamChunDang Pharm. Co., Ltd. BLA 761494 (SCD411)
2026-08-18Complete response lettercomplete responseXspray Pharma ABCRL 2026-08-18: Xspray Pharma AB NDA 216195
2026-08-19FDA approvalapprovedREGENERON PHARMACEUTICALS, INC REGNPASATRUApproved 2026-08-19: PASATRU (BLA761508 ORIG1)
2026-08-20FDA approvalapprovedAPELLIS PHARMSEMPAVELIApproved 2026-08-20: EMPAVELI (NDA215014 SUPPL12)
2026-08-23PDUFA date (company-disclosed)date passedUltragenyx Pharmaceutical Inc. RARErebisufligenePDUFA August 23, 2026 - Ultragenyx Pharmaceutical Inc. (rebisufligene)
2026-08-24FDA approvalapprovedJANSSEN BIOTECHIMAAVYApproved 2026-08-24: IMAAVY (BLA761430 SUPPL2)
2026-08-25FDA approvalapprovedBEIGENETEVIMBRAApproved 2026-08-25: TEVIMBRA (BLA761232 SUPPL18)
2026-08-25FDA approvalapprovedJAZZ PHARMS JAZZZIIHERAApproved 2026-08-25: ZIIHERA (BLA761416 SUPPL2)
2026-08-25FDA approvalapprovedVIIV HLTHCARETIVICAYApproved 2026-08-25: TIVICAY (NDA204790 SUPPL34)
2026-08-25FDA approvalapprovedVIIV HLTHCARETIVICAY PDApproved 2026-08-25: TIVICAY PD (NDA213983 SUPPL7)
2026-08-25PDUFA date (company-disclosed)date passedZymeworks Inc. ZYMEzanidatamabPDUFA August 25, 2026 - Zymeworks Inc. (zanidatamab)
2026-08-26FDA approvalapprovedELI LILLY AND CO LLYZEPBOUND ZEPBOUND KWIKPENApproved 2026-08-26: ZEPBOUND; ZEPBOUND (AUTOINJECTOR); ZEPBOUND KWIKPEN (NDA217806 SUPPL41)
2026-08-26FDA approvalapprovedREVOLUTION MEDICINES RVMDRASONQUEApproved 2026-08-26: RASONQUE (NDA220910 ORIG1)
2026-08-26FDA approvalapprovedSUN PHARMVOBRIGApproved 2026-08-26: VOBRIG (NDA213225 ORIG1)
2026-08-27FDA approvalapprovedELI LILLY AND CO LLYMOUNJARO MOUNJARO KWIKPENApproved 2026-08-27: MOUNJARO; MOUNJARO (AUTOINJECTOR); MOUNJARO KWIKPEN (NDA215866 SUPPL44)
2026-08-27FDA approvalapprovedELI LILLY AND CO LLYMOUNJARO MOUNJARO KWIKPENApproved 2026-08-27: MOUNJARO; MOUNJARO (AUTOINJECTOR); MOUNJARO KWIKPEN (NDA215866 SUPPL45)
2026-08-27FDA approvalapprovedGILEAD SCIENCES INC GILDBIXLENVOApproved 2026-08-27: BIXLENVO (NDA221104 ORIG1)
2026-08-27FDA approvalapprovedGILEAD SCIENCES INC GILDBIXLENVO SUNLENCA STARTER PACKApproved 2026-08-27: BIXLENVO SUNLENCA STARTER PACK (COPACKAGED) (NDA221443 ORIG1)
2026-08-27FDA approvalapprovedGILEAD SCIENCES INC GILDSUNLENCAApproved 2026-08-27: SUNLENCA (NDA215973 SUPPL24)
2026-08-27FDA approvalapprovedGILEAD SCIENCES INC GILDSUNLENCAApproved 2026-08-27: SUNLENCA (NDA215974 SUPPL17)
2026-08-27FDA approvalapprovedPRIOVANT THERAPLISRAYAApproved 2026-08-27: LISRAYA (NDA220106 ORIG1)
2026-08-28FDA approvalapprovedPHARMAESSENTIA CORPBESREMIApproved 2026-08-28: BESREMI (BLA761166 SUPPL13)
2026-08-28FDA approvalapprovedTAKEDA PHARMS AM TAKMIMRYLOApproved 2026-08-28: MIMRYLO (NDA220605 ORIG1)
2026-08-28FDA approvalapprovedJANSSEN BIOTECHSTELARAApproved 2026-08-28: STELARA (BLA761044 SUPPL21)

Trial readouts

ReadoutPhaseSponsorTrialConditionsStatusEnrollment
2026-08 est.P2VivaTech International, Inc.NCT02844738 Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the ShoulderOsteoarthritisrecruiting4000
2026-08 est.P2VivaTech International, Inc.NCT02844751 Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the KneeOsteoarthritisrecruiting4000
2026-08 est.P2VivaTech International, Inc.NCT02844764 Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the HipOsteoarthritisrecruiting4000
2026-08 est.P3AbbVie ABBVNCT03539744 A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in ParticiMultiple Myelomaactive not recruiting265
2026-08 est.P1/P2AtlasMedx, IncorporatedNCT04503265 A Trial of AMXI-5001 for Treatment in Patients With Advanced MalignanciesAdvanced Malignant Neoplasm; Breast Cancer; Ovarian Cancer; Homologous Recombination Deficiency; Prorecruiting122
2026-08 est.P1/P2Allist Pharmaceuticals, Inc.NCT05009329 A Study of JAB-21822 in Adult Patients With Advanced Solid Tumors Harboring KRAS p.G12C Mutation in ChinaNSCLC; Solid Tumoractive not recruiting315
2026-08 est.P1/P2BicycleTx LimitedNCT05163041 Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 ExpressionAdvanced Solid Tumoractive not recruiting200
2026-08 est.P1/P2AB ScienceNCT05211570 AB8939 in Patients With Relapsed/Refractory Acute Myeloid LeukemiaAcute Myeloid Leukemia Refractory; Acute Myeloid Leukemia, in Relapse; Myelodysplastic Syndrome Acutrecruiting78
2026-08 est.P1/P2Treadwell Therapeutics, IncNCT05251714 CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast CancerAdvanced Solid Tumor; Breast Canceractive not recruiting44
2026-08 est.P2Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. SKBBYNCT05351788 SKB264 Combinatiton Therapy in Patients With Advanced or Metastatic Non-small Cell Lung Cancer.Non-small Cell Lung Cancerrecruiting110
2026-08 est.P1/P2Jacobio Pharmaceuticals Co., Ltd.NCT05490472 JAB-2485 Activity in Adult Patients With Advanced Solid TumorsSolid Tumors; ER+ Breast Cancer; Triple Negative Breast Cancer, TNBC; ARID1A Gene Mutation; Small Cerecruiting102
2026-08 est.P2CrystalGenomics, Inc.NCT05841472 Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Non Squamous Non Small Cell Lung Cancerrecruiting60
2026-08 est.P3CELL Technologies Inc.NCT06216028 Bone Marrow Aspirate Concentrate (BMAC) Treatment for Knee OsteoarthritisKnee Osteoarthritis; Musculoskeletal Diseasesnot yet recruiting374
2026-08 est.P3Sichuan Baili Pharmaceutical Co., Ltd.NCT06343948 A Study Comparing BL-B01D1 With Chemotherapy of Physician's Choice in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic HR+HER2- Breast CancHR+HER2- Breast Canceractive not recruiting383
2026-08 est.P3Sichuan Baili Pharmaceutical Co., Ltd.NCT06382116 A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer(PANKU-Lung01)Non-small Cell Lung Canceractive not recruiting432
2026-08 est.P3Yantai LNC Biotechnology Singapore PTE. LTD.NCT06416852 Clinical Study of 18F-Alfatide Injection PET/CTNon-Small Cell Lung Cancer NSCLCnot yet recruiting428
2026-08 est.P2Cornerstone Pharmaceuticals CLMNCT06518538 Evaluate Efficacy of Devimistat in Combination With mFFX in 2nd Line Patients With Metastatic Pancreatic CancerPancreatic Cancer Stage IVwithdrawn
2026-08 est.P2Veradermics, Inc. MANENCT06527365 Safety and Efficacy of VDPHL01 in Males and Females With AGAAndrogenetic Alopecia; AGA; Male Pattern Baldnessactive not recruiting70
2026-08 est.P3CerevanceNCT06553027 To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsParkinson Diseaseactive not recruiting330
2026-08 est.P3Ensysce Biosciences ENSCNCT06602271 PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)Postoperative Pain, Acuterecruiting320
2026-08 est.P2Tasly Biopharmaceuticals Co., Ltd.NCT06724263 A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid TumorsRecurrent Platinum-resistant Epithelial Ovarian Cancer; Triple Negative Breast Cancer (TNBC); Cervicnot yet recruiting120
2026-08 est.P3Shanghai Mabgeek Biotech.Co.LtdNCT06779136 Phase III Clinical Study of MG-K10 Humanized Mab Injection in Subjects With Prurigo NodularisPrurigo Nodularisrecruiting160
2026-08 est.P2Clinique OvoNCT06997900 Menopur And Rekovelle Combination Study Version 2.0IVF; Controlled Ovarian Simulation; Fertility Disordersrecruiting200
2026-08 est.P1/P2Jiangsu HengRui Medicine Co., Ltd.NCT07056439 Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer PatientsPET Imaging in Patients With Prostate Cancernot yet recruiting50
2026-08 est.P2Suzhou Suncadia Biopharmaceuticals Co., Ltd.NCT07110571 A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ CancerGastric Cancer; Gastroesophageal-junction Cancerrecruiting200
2026-08 est.P3Pharmbio Korea Co., Ltd.NCT07114406 A Study to Evaluate Safety and Efficacy of PBK_M2502Intestinal Disease; Colonic Diseases; Gastrointestinal Disease; Digestive System Diseasenot yet recruiting110
2026-08 est.P2Shandong Suncadia Medicine Co., Ltd.NCT07229937 A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With DyslipidemiaHyperlipidemiarecruiting189
2026-08 est.P3Mirum Pharmaceuticals, Inc. MIRMNCT07298330 A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)Chronic Hepatitis D Infectionactive not recruiting80
2026-08 est.P3Invivyd, Inc. IVVDNCT07298434 Study of VYD2311 for the Prevention of COVID-19COVID-19active not recruiting1770
2026-08 est.P2Rebel Medicine IncNCT07574385 Sciatic Nerve Block With ALX006 in Subjects Undergoing BunionectomyHallux Valgus; Bunionectomyrecruiting60
2026-08 est.P2Shanghai QuietD Biotechnology Co., Ltd.NCT07581210 Efficacy and Safety of QD202 in Participants With Acute Ischemic Stroke Undergoing Thrombolysis Excluding Endovascular ThrombectomyAcute Ischemic Strokerecruiting120
2026-08-01 est.P1/P2Bridge Biotherapeutics, Inc.NCT05920135 First-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKIEGFR Mutant Advanced Non-Small Cell Lung Canceractive not recruiting24
2026-08-01 est.P1/P2OncoResponse, Inc.NCT06090266 A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer AgentsCancer; Tumor, Solid; Malignant Neoplasm; Metastatic Cancer; Advanced Solid Tumor; Cutaneous Melanomrecruiting168
2026-08-01 est.P3Santen SASNCT06514612 LIDRISE Study: A Phase 3 Study on the Efficacy and Safety of STN1013800 (Oxymetazoline HCl 0.1% Eye Drops, Single Dose) in the Treatment of Acquired BlepharoptoAcquired Blepharophimosisrecruiting234
2026-08-01P1/P2Implicit BioscienceNCT06678074 Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMISTEMI; STEMI (ST Elevation MI); STEMI - ST Elevation Myocardial Infarction (MI); Stent Implantationcompleted7
2026-08-01 est.P3Gan & Lee Pharmaceuticals.NCT06767735 A Phase III Clinical Study to Assess the Efficacy and Safety of GZR4 in Insulin-naive Subjects With Type 2 Diabetes Mellitus (T2DM)Diabetesactive not recruiting580
2026-08-01 est.P3Jiangxi Kvvit Pharmaceutical Co., Ltd.NCT07113392 A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for SuspensionInfluenzanot yet recruiting144
2026-08-01 est.P3Innovent Biologics (Suzhou) Co. Ltd.NCT07469800 Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/ObesityOverweight; Obesity; Hypertensiverecruiting336
2026-08-01 est.P3Sinovac (Dalian) Vaccine Technology Co., Ltd.NCT07473427 Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Vietnamese ChildrenVaricella (Chickenpox); Varicella Immunisationnot yet recruiting300
2026-08-02 est.P2Ausper Biopharma Co., Ltd.NCT06829329 Study to Evaluate the Efficacy and Safety of AHB-137 in Treatment-naive Participants With Chronic Hepatitis B (CHB)Chronic Hepatitis Bactive not recruiting105
2026-08-03P2Merck Sharp & Dohme LLC MRKNCT06465186 A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)Non-alcoholic Fatty Liver Disease; Nonalcoholic Steatohepatitis; NAFLD; Metabolic Dysfunction-associcompleted85
2026-08-03P2Eli Lilly and Company LLYNCT06598943 A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative ColitisUlcerative Colitis; Ulcerative Colitis Chronicactive not recruiting143
2026-08-03 est.P2Catalysis SLNCT07179237 Efficacy of Carminal in Helicobacter Pylori GastritisH Pylori Gastritis; H Pylori Infection; H Pylori Eradication; Gastritis Associated With Helicobacterrecruiting80
2026-08-03P3Merck Sharp & Dohme LLC MRKNCT07216482 A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037)Hyperlipidemiacompleted996
2026-08-03P2Shanghai Xin Huanghe Pharmaceutical Co., Ltd.NCT07807007 Efficacy and Safety of CP006 Inhalation Powder in Participants With AsthmaAsthmacompleted150
2026-08-04P2/P3Genzyme, a Sanofi CompanyNCT03974113 Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or BHemophiliacompleted32
2026-08-04P3Celldex Therapeutics CLDXNCT06455202 A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)Chronic Spontaneous Urticariaactive not recruiting976
2026-08-05P2Boehringer IngelheimNCT06241560 A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the BloodIdiopathic Pulmonary Fibrosiscompleted20
2026-08-05P2Brii Biosciences LimitedNCT06491563 Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH)For Treatment of Chronic Hepatitis B Virus Infectioncompleted150
2026-08-05P2Sanofi SNYNCT06557772 A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac DiseaseCoeliac Disease; Celiac Diseaseactive not recruiting229
2026-08-05P2/P3Glycomine, Inc.NCT06892288 A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants With PMM2-CDGPhosphomannomutase 2 Deficiency; PMM2-CDGactive not recruiting50
2026-08-05P2Rapport Therapeutics Inc. RAPPNCT07046494 Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I DisorderBipolar 1 Disordercompleted253
2026-08-05P3Merz Aesthetics GmbHNCT07210463 A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)Neuromuscular Agents; Peripheral Nervous System Agents; Physiological Effects of Drugs; Acetylcholinactive not recruiting300
2026-08-05P3RDC Clinical Pty LtdNCT07241377 A Study in Healthy Adults to Compare the Bioavailability of EPA + DHA From Two Microalgal Sources to One Fish Source and PlaceboAbsorption of Omega-3; Omega-3 Supplementation; Healthy Participantscompleted120
2026-08-06P2GlaxoSmithKlineNCT06213506 A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and InfanSalmonella Infectionscompleted180
2026-08-06P2BioVie Inc. BIVINCT06847191 NE3107 in Adults With Neurological Symptoms of Long COVIDLong COVIDcompleted203
2026-08-06P2Sanofi SNYNCT06867094 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative ColitisColitis Ulcerativeterminated170
2026-08-06P3Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07357831 A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis SubjectsPlaque Psoriasiscompleted539
2026-08-07P3Incyte Corporation INCYNCT06832618 A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic DermatitisAtopic Dermatitisactive not recruiting159
2026-08-09P3UCB Biopharma SRLNCT04436640 A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing SpondyliAxial Spondyloarthritis; Ankylosing Spondylitis; r-axSpa; Nr-axSpacompleted508
2026-08-10P1/P2Merck Sharp & Dohme LLC MRKNCT04626479 Substudy 03A: A Study of Immune and Targeted Combination Therapies in Participants With First Line (1L) Renal Cell Carcinoma (MK-3475-03A)Carcinoma, Renal Cellcompleted393
2026-08-10P3AstraZeneca AZNNCT05211895 A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLCNon-Small Cell Lung Canceractive not recruiting791
2026-08-10P3AstraZeneca AZNNCT05267613 Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.Erosive Esophagitiscompleted53
2026-08-10 est.P1/P2ModernaTX, Inc.NCT06147856 A Dose-finding Study to Evaluate mRNA-3210 in Participants With PhenylketonuriaPhenylketonuriawithdrawn
2026-08-10P2BioArctic ABNCT06671938 Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System AtrophyParkinson Disease; Multiple System Atrophycompleted38
2026-08-10P2AstraZeneca AZNNCT06681324 Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an IleostomyCrohn's Diseaseactive not recruiting24
2026-08-10P2Ascletis Pharma (China) Co., LimitedNCT07321678 A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes MellitusT2DM (Type 2 Diabetes Mellitus)completed100
2026-08-11P1/P2Bristol-Myers Squibb BMYNCT06035497 A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas iRelapsed or Refractory T-cell Lymphomasactive not recruiting83
2026-08-11P2EMD Serono Research & Development Institute, Inc.NCT06433219 Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302)Ovarian Cancercompleted63
2026-08-11 est.P2ZyVersa Therapeutics, Inc.NCT06489340 P2a Open Label Study to Evaluate 2-HPβCD in Subjects With Diabetic Kidney DiseaseDiabetic Kidney Diseasewithdrawn
2026-08-11P3HALEON HLNNCT07215767 Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel DentifriceDentin Hypersensitivitycompleted688
2026-08-12P1/P2Alpine Immune Sciences Inc, A Subsidiary of VertexNCT05757570 An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias (RUBY-4)Idiopathic Thrombocytopenic Purpura; Immune Thrombocytopenia; Warm Autoimmune Hemolytic Anemia; Coldcompleted30
2026-08-12P3DualityBio Inc.NCT06018337 A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)Metastatic Breast Canceractive not recruiting541
2026-08-12P3Merck Sharp & Dohme LLC MRKNCT06052059 A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)Ulcerative Colitisactive not recruiting1109
2026-08-12P3Amgen AMGNNCT06088199 A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque PsoriasisPlaque Psoriasiscompleted51
2026-08-12P2argenx ARGXNCT06441682 A Safety and Efficacy Study of ARGX-119 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)Amyotrophic Lateral Sclerosisterminated60
2026-08-12P3Celldex Therapeutics CLDXNCT06445023 A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous UrticariaChronic Spontaneous Urticariaactive not recruiting963
2026-08-12P2EnnovaBioNCT06708260 A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects With DMEDiabetic Macular Edema (DME)completed60
2026-08-12P2Pharming Technologies B.V. PHARNCT06897358 Leniolisib for Immune Dysregulation in CVIDCommon Variable Immunodeficiency (CVID)completed27
2026-08-12P3Akebia Therapeutics AKBANCT06901505 To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center HemodialysisAnemia of Chronic Kidney Diseasecompleted353
2026-08-12P3pH-D Feminine Health LLCNCT07109869 Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal CandidiasisVulvovaginal Candidiases; Vulvovaginal Candidiasis, Genital; Vulvovaginal Candidiasis (VVC)completed333
2026-08-13P1/P2Hoffmann-La RocheNCT03157635 Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal HemoglobParoxysmal Hemoglobinuria, Nocturnalcompleted59
2026-08-13P3BrightGene Bio-Medical Technology Co., Ltd.NCT06716203 A Study of BGM0504 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and ExerciseType 2 Diabetes Mellitus (T2DM)completed227
2026-08-13P3Definium Therapeutics US, Inc. DFTXNCT06809595 A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)Generalized Anxiety Disorderactive not recruiting245
2026-08-13P2Zealand Pharma ZEAL.CONCT06926842 Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)Overweight; Type 2 Diabetes; Obesitycompleted221
2026-08-13 est.P2Hinova Pharmaceuticals Inc.NCT07308548 A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH )NAFLD (Non-alcoholic Fatty Liver Disease)recruiting80
2026-08-14 est.P1/P2Healeon Medical IncNCT02946658 Use of Autologous, Adult Adipose-Derived Stem/Stromal Cells In Chronic Lung DisordersLung Diseasesuspended100
2026-08-14P1/P2TCM Biotech International Corp.NCT03812874 A Study of PTX-9908 Injection for Non-resectable HCC With TACECarcinoma, Hepatocellularwithdrawn
2026-08-14P3Jiangsu HengRui Medicine Co., Ltd.NCT06507436 The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive SurgeryThrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgerycompleted127
2026-08-14P2Boehringer IngelheimNCT06926660 A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney DiseaseChronic Kidney Diseasecompleted492
2026-08-14P2AstraZeneca AZNNCT07143604 A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.Gastric Cancer; Gastroesophageal Junction Canceractive not recruiting33
2026-08-14P2Jiangsu HengRui Medicine Co., Ltd.NCT07372924 A Trial of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation Abirritation in the Intensive Care Unit (ICU)Abirritation in the ICUcompleted121
2026-08-15 est.P2Telavant, Inc.NCT05471492 Study to Evaluate the Efficacy and Safety of PF-06480605 in Adult Participants With Moderate to Severe Crohn's DiseaseCrohn Diseasewithdrawn
2026-08-15P3Invivyd, Inc. IVVDNCT07655180 Safety and Serum Virus Neutralizing Antibody Responses of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 VaccineCOVID-19completed210
2026-08-16 est.P2JenKem Technology Co., Ltd.NCT06595186 JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)Glioblastoma Multiforme (GBM)recruiting25
2026-08-17P2AbbVie ABBVNCT03339128 Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in ChildrenIrritable Bowel Syndromecompleted272
2026-08-17P3AstraZeneca AZNNCT05984277 A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.Metastatic Non-small Cell Lung Canceractive not recruiting895
2026-08-17P3Neumora Therapeutics, Inc. NMRANCT06029439 Study to Assess the Safety and Effectiveness of NMRA-335140-501Major Depressive Disorderterminated904
2026-08-17P2NeuroPro Therapeutics, Inc.NCT06769659 A Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence SeizuresEpilepsy, Generalized; Epilepsy, Absencecompleted14
2026-08-17P2Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USANCT07016412 Clinical Study of Ensifentrine-Glycopyrrolate (MK-5884A/RPL554) Fixed-dose Combination Dose Ranging in Participants With COPD (MK-5884A-029/RPL554-CO-212)Chronic Obstructive Pulmonary Diseasecompleted497
2026-08-18P2Janssen Sciences Ireland UCNCT02494986 A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric StudiesHuman Immunodeficiency Virus Type 1completed48
2026-08-18 est.P3Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.NCT06519370 FDA018-ADC vs Investigator's Choice Chemotherapy to Treat Locally Advanced, Recurrent or Metastatic Triple-negative Breast CancerTriple Negative Breast Canceractive not recruiting350
2026-08-18P3Genmab GMABNCT06619236 Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian CancerPlatinum-resistant Ovarian Canceractive not recruiting584
2026-08-18 est.P2Merck Sharp & Dohme LLC MRKNCT06864169 A Study of Raludotatug Deruxtecan (R-DXd) in People With Gastrointestinal Cancers (MK-5909-005)Gastrointestinal Canceractive not recruiting160
2026-08-18P2Innovent Biologics (Suzhou) Co. Ltd.NCT07330934 A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic DermatitisAtopic Dermatitisterminated18
2026-08-19P2Novartis Pharmaceuticals NVSNCT05230537 A Masked, Placebo-controlled Study to Assess Iptacopan in Age-related Macular DegenerationAge-Related Macular Degenerationcompleted168
2026-08-19P3ViiV HealthcareNCT06694805 A Study to Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1HIV Infectionsactive not recruiting326
2026-08-20P3Ardelyx ARDXNCT05643534 Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 YearsIrritable Bowel Syndrome With Constipation (IBS-C)completed180
2026-08-20P3Sol-Gel Technologies, Ltd. SLGLNCT06050122 Efficacy and Safety of Patidegib Gel 2% for Preventing Basal Cell Carcinomas on the Face of Adults With Gorlin SyndromeGorlin Syndromecompleted113
2026-08-20P3Hansoh BioMedical R&D CompanyNCT06498479 ARTEMIS-008:HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung CancerSmall Cell Lung Cancercompleted461
2026-08-21P2Endeavor Biomedicines, Inc.NCT06422884 A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)Idiopathic Pulmonary Fibrosis; Progressive Fibrosing Interstitial Lung Diseasecompleted213
2026-08-21P2NodThera Ltd. (a Rezera company)NCT07220629 Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2)Obesitycompleted82
2026-08-21P3AbbVie ABBVNCT07284381 A Clinical Study to Evaluate the Effect and Side Effect of a New Artificial Tear Formulation (ABBV-444) Compared to Refresh Optive Unit Dose in Adult ParticipanDry Eye Diseasecompleted261
2026-08-22 est.P2Bazelet Nehushtan LtD.NCT06542445 The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHDAttention Deficit Hyperactivity Disorder (ADHD)unknown120
2026-08-24 est.P3Alexion Pharmaceuticals, Inc.NCT05389449 A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNHParoxysmal Nocturnal Hemoglobinuriaactive not recruiting80
2026-08-24 est.P2Regeneron Pharmaceuticals REGNNCT06161441 A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in AResectable Non-small Cell Lung Canceractive not recruiting195
2026-08-24P2GlaxoSmithKlineNCT07204964 A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and AboveInfluenza, Humancompleted971
2026-08-25P1/P2Hoffmann-La RocheNCT04567303 Study of Zifibancimig in Participants With Neovascular Age-related Macular DegenerationMacular Degenerationcompleted177
2026-08-25 est.P2BPGbioNCT04752813 A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)Glioblastoma; Glioblastoma Multiformeactive not recruiting50
2026-08-25P2Hoffmann-La RocheNCT05634499 A Study of Giredestrant in Participants With Grade 1 Endometrial CancerEndometrial Cancercompleted33
2026-08-25P1/P2Crinetics Pharmaceuticals Inc.NCT05804669 A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's SyndromeCushing Syndrome; Cushing Disease; Ectopic ACTH Syndromecompleted19
2026-08-25P3BrightGene Bio-Medical Technology Co., Ltd.NCT06716216 A Study of BGM0504 in Participants With Type 2 DiabetesType 2 Diabetes Mellitus (T2DM)completed553
2026-08-25P3PDS Biotechnology Corp. PDSBNCT06790966 Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaRecurrent Head and Neck Cancer; Metastatic Head and Neck Cancer; HPV Positive Oropharyngeal Squamousterminated12
2026-08-25P3Pfizer PFENCT07543380 A Study to Learn Safety and Immune Response to Study Vaccine -RSVpreF in Adults at High Risk of Severe RSV Disease.Respiratory Syncytial Virus (RSV)completed130
2026-08-26P2UCB BIOSCIENCES, Inc.NCT03845712 An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 DeficiencyThymidine Kinase 2 Deficiencycompleted47
2026-08-26P3Pfizer PFENCT06152575 MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other TreatmentMultiple Myelomarecruiting492
2026-08-26P3Guangdong Hengrui Pharmaceutical Co., LtdNCT06468956 Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic DermatitisModerate to Severe Atopic Dermatitiscompleted652
2026-08-26 est.P1/P2Shanghai Runshi Pharmaceutical Technology Co., LtdNCT06577376 A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction AdenocarcinomaLocalized Advanced or Metastatic Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma;not yet recruiting252
2026-08-26P3Innovent Biologics (Suzhou) Co. Ltd.NCT07473960 IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed HyperlipidemiaNon-Familial Hypercholesterolemia and Mixed Hyperlipidemiacompleted198
2026-08-26 est.P2ParagonClinicals Inc.NCT07627815 Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVIDLong COVIDrecruiting82
2026-08-27 est.P1/P2Blue Earth Therapeutics LtdNCT05413850 Anti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionProstate Cancer; Metastatic Castration-resistant Prostate Cancer; mCRPC; Urogenital Neoplasms; Prostrecruiting82
2026-08-27P2Syndax Pharmaceuticals SNDXNCT06132256 MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)Idiopathic Pulmonary Fibrosiscompleted145
2026-08-27P1/P2Chiesi Farmaceutici S.p.A.NCT06166056 A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Inhaled CHF6333 After Single Doses in Healthy Volunteers and After Single and Repeated Bronchiectasiscompleted108
2026-08-27P3Eli Lilly and Company LLYNCT06260722 Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Diabetes Mellitus, Type 2active not recruiting1250
2026-08-28P2/P3Hutchmed HCMNCT05522231 Efficacy and Safety of Fruquintinib in Combination With Sintilimab in Advanced Renal Cell Carcinoma (FRUSICA-2)Advanced Renal Cell Carcinomacompleted265
2026-08-28P3Arcus Biosciences, Inc. RCUSNCT05568095 A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That CAdvanced Upper Gastrointestinal Tract Adenocarcinomacompleted1040
2026-08-29 est.P2/P3Panbela Therapeutics, Inc.NCT05254171 Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic CancerPancreatic Cancer Metastatic; Pancreatic Ductal Adenocarcinoma; Pancreatic Cancer Stage IVrecruiting600
2026-08-29P3Bracco Diagnostics, IncNCT06400004 Lumason® Infusion vs. Bolus AdministrationsHeart Diseasesrecruiting106
2026-08-30P2OncoC4, Inc.NCT05446298 ONC-392 and Pembrolizumab in Platinum Resistant Ovarian CancerOvarian Cancer; High Grade Serous Adenocarcinoma of Ovary; Primary Peritoneal Carcinoma; Fallopian Tactive not recruiting58
2026-08-30 est.P1/P2Fujian Haixi Pharmaceuticals Co., Ltd.NCT06220318 Assessment of the Safety and Efficacy of C019199 Plus Sintilimab in Participants With Advanced Solid TumorsSolid Tumoractive not recruiting155
2026-08-30 est.P2Fujian Shengdi Pharmaceutical Co., Ltd.NCT06425341 A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Chronic Hepatitis Brecruiting369
2026-08-30 est.P3Keymed Biosciences Co.LtdNCT06495229 Study of CM310 in Adolescent Subjects With Atopic DermatisAtopic Dermatitisactive not recruiting180
2026-08-30P1/P2Implicit BioscienceNCT06556810 IC14 for Treatment of Acute Decompensated Heart FailureAcute Decompensated Heart Failurecompleted10
2026-08-30 est.P3Beletalent (Zhuhai) Pharmaceutical Co., LtdNCT06817265 Clinical Study on the Efficacy and Safety of TNTL in the Treatment of Non-proliferative Diabetic RetinopathyNon-Proliferative Diabetic Retinopathyrecruiting360
2026-08-30 est.P2TJ Biopharma Co., Ltd.NCT07005336 A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated LocaNon Small Cell Lung Canceractive not recruiting150
2026-08-30 est.P2Haisco Pharmaceutical Group Co., Ltd.NCT07108699 Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary Disease (COPD)active not recruiting180
2026-08-30 est.P2Innovent Biologics Technology Limited (Shanghai R&D Center)NCT07275840 A Study to Evaluate the Efficacy and Safety of IBI302inSubjects With nAMDNeovascular Age-related Macular Degenerationrecruiting800
2026-08-31 est.P3AMAG Pharmaceuticals, Inc.NCT03619850 A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in PedChronic Kidney Disease; Iron Deficiency Anemiarecruiting129
2026-08-31P3Idorsia Pharmaceuticals Ltd.NCT03737214 A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry DiseaseFabry Diseasecompleted107
2026-08-31P3Galderma R&DNCT03989206 Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic DermatitisModerate-to-Severe Atopic Dermatitiscompleted1935
2026-08-31 est.P3Daiichi SankyoNCT04704934 Trastuzumab Deruxtecan for Subjects With HER2-Positive Gastric Cancer or Gastro-Esophageal Junction Adenocarcinoma After Progression on or After a Trastuzumab-CGastric Cancer, Adenocarcinoma; Gastroesophageal Junction Adenocarcinomaactive not recruiting490
2026-08-31 est.P1/P2Myrtelle Inc.NCT04833907 rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan DiseaseCanavan Diseaseenrolling by invitation24
2026-08-31P2/P3Lumen Bioscience, Inc. LUMNNCT05330182 LMN-201 for Prevention of C. Difficile Infection RecurrenceClostridioides Difficile Infectionactive not recruiting375
2026-08-31 est.P2Translational Sciences, Inc.NCT05408546 Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) TrialPulmonary Embolismactive not recruiting64
2026-08-31 est.P2Kadmon, a Sanofi CompanyNCT05567406 Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and FChronic Graft Versus Host Diseasewithdrawn
2026-08-31 est.P1/P2Verastem, Inc. VSTMNCT05669482 Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic CancerKRAS Activating Mutation; Metastatic Cancer; Pancreas Cancer; Neoplasms Pancreatic; Malignant Neoplaactive not recruiting40
2026-08-31P2Klus Pharma Inc.NCT05816252 A Study of SKB264 (MK-2870; Sac-TMT) for the Treatment of Participants With Advanced or Metastatic Non-small Cell Lung Cancer (SKB264-II-04) (MK-2870-003)Non-small Cell Lung Canceractive not recruiting356
2026-08-31P3Cytokinetics CYTKNCT06081894 A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)Symptomatic Non-Obstructive Hypertrophic Cardiomyopathyactive not recruiting500
2026-08-31 est.P3Sichuan Jishengtang Pharmaceutical Co., Ltd.NCT06534723 Phase 3 Clinical Trial of Wujia Yizhi Granules in the Treatment of Mild-to-moderate Alzheimer's Dementia (Syndrome of Deficiency of Spleen and Kidney)Alzheimer's Dementiarecruiting570
2026-08-31 est.P3Santen Pharmaceutical Co., Ltd.NCT06666855 A Phase III Study in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension in ChinaOpen Angle Glaucoma; Ocular Hypertensionactive not recruiting345
2026-08-31 est.P3mAbxience Research S.L.NCT06687369 A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) to Keytruda® in Non-small Cell Lung CancerNon Squamous Non Small Cell Lung Canceractive not recruiting726
2026-08-31 est.P2Nantong Bencao Quadriga Medical Technology Co. Ltd.NCT06810804 A Phase IIa Study to Evaluate NBQ72SBreast Cancerrecruiting10
2026-08-31P3Arthrosi TherapeuticsNCT06846515 Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)Gout; Arthritis, Gouty; Hyperuricemia; Gout Chroniccompleted866
2026-08-31P3ALK-Abelló A/SNCT07060885 A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65Allergic Rhinoconjunctivitis; Allergic Rhinitiscompleted327
2026-08-31 est.P3Daewon Pharmaceutical Co., Ltd.NCT07168473 Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With AsthmaPerennial Allergic Rhinitis Accompanied by Asthmarecruiting274
2026-08-31 est.P2Shenyang Sunshine Pharmaceutical Co., LTD.NCT07171606 A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer(NSCLC) PatientsFirst-line Advanced NSCLC Patientsrecruiting240
2026-08-31P24Moving BiotechNCT07225829 A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and OsteoarthritisKnee Osteoarthritis; Synovitis of Kneecompleted130
2026-08-31P3Inozyme PharmaNCT07473973 ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1 DeficiencyEctonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency; Autosomal Recessive Hypophosphatemic Rterminated2
2026-08-31P3Daewon Pharmaceutical Co., Ltd.NCT07931521 Clinical Trial to Evaluate the Safety and Efficacy of DW4421 in Patients With Erosive Reflux DiseaseErosive Reflux Disease; GERD (Gastroesophageal Reflux Disease)completed328

← 2026-07 | 2026-09 →

Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA (openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score. Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP readout_calendar / fda_decisions. Not investment advice.